Seems the minority is becoming of one the way the reality of the situation is presenting itself.
I'll take the position that whatever the take on the status of THIS IND or subsequent interpretations of resolved "dialogue", nothing changes at least through this Summer.
Advocates can line up their resource material to defend a proposition, but in the end those who rely LEAST on "sounds like to me" will succeed the most.
Jonjones posted about it after attending the annual meeting. He said juvenile toxicity study may need to be done per FDA’s request. Does it sound like a clinical hold?